Skip to main content

FDA & Regulatory

Priority Review

Priority Review shortens the FDA’s target review time from the standard ~10 months to ~6 months for drugs that would significantly improve the treatment of a serious condition. It is granted at filing and is often paired with a Priority Review Voucher in qualifying cases.

Category
FDA & Regulatory
BioSniper AIPage evidence connected

Prepared research question

How does Priority Review affect the view of a biotech company in practice?

Run cited research

Traceable citations · Unknowns marked

Priority Review shortens the FDA’s target review time from the standard ~10 months to ~6 months for drugs that would significantly improve the treatment of a serious condition. It is granted at filing and is often paired with a Priority Review Voucher in qualifying cases.

Related terms

Learn more

From term to thesis rule

Investigate how Priority Review changes a biotech thesis

Define when Priority Review should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.